Skip to content

EBIT at other companies

Haemonetics logo
HaemoneticsHAE
$67.4M+14.2%
ITG
Integer HoldingsITGR
$31.87M-35.7%
Abbott logo
AbbottABT
Medtronic logo
MedtronicMDT
Boston Scientific logo
Boston ScientificBSX
Stryker logo
StrykerSYK

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Calculated from LivaNova’s reported figures.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's EBIT?
LivaNova (LIVN) reported EBIT of $41.47M in Q1 2026.
How has LivaNova's EBIT changed year-over-year?
LivaNova's EBIT decreased by 14.7% year-over-year, from $48.62M to $41.47M.
What is the long-term trend for LivaNova's EBIT?
Over 4 years (2021 to 2025), LivaNova's EBIT has grown at a 299.3% compound annual growth rate (CAGR), from -$784K to $199.39M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.